AT345979B - Verfahren zur herstellung von neuen 16-aethern von fusidinsaeurederivaten - Google Patents

Verfahren zur herstellung von neuen 16-aethern von fusidinsaeurederivaten

Info

Publication number
AT345979B
AT345979B AT438776A AT438776A AT345979B AT 345979 B AT345979 B AT 345979B AT 438776 A AT438776 A AT 438776A AT 438776 A AT438776 A AT 438776A AT 345979 B AT345979 B AT 345979B
Authority
AT
Austria
Prior art keywords
fusidine
ethers
acid derivatives
manufacturing new
manufacturing
Prior art date
Application number
AT438776A
Other languages
German (de)
English (en)
Other versions
ATA438776A (de
Original Assignee
Leo Pharm Prod Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB26989/75A external-priority patent/GB1523803A/en
Application filed by Leo Pharm Prod Ltd filed Critical Leo Pharm Prod Ltd
Publication of ATA438776A publication Critical patent/ATA438776A/de
Application granted granted Critical
Publication of AT345979B publication Critical patent/AT345979B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J13/00Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
    • C07J13/007Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 17 (20)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J31/00Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/003Normal steroids containing one or more sulfur atoms not belonging to a hetero ring the S atom directly linked to a ring carbon atom of the cyclopenta(a)hydrophenanthrene skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0055Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J43/00Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
AT438776A 1975-06-25 1976-06-16 Verfahren zur herstellung von neuen 16-aethern von fusidinsaeurederivaten AT345979B (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB26989/75A GB1523803A (en) 1975-06-25 1975-06-25 16-ethers of fusidic acid derivatives
GB4622975 1975-11-07

Publications (2)

Publication Number Publication Date
ATA438776A ATA438776A (de) 1978-02-15
AT345979B true AT345979B (de) 1978-10-10

Family

ID=26258548

Family Applications (1)

Application Number Title Priority Date Filing Date
AT438776A AT345979B (de) 1975-06-25 1976-06-16 Verfahren zur herstellung von neuen 16-aethern von fusidinsaeurederivaten

Country Status (18)

Country Link
JP (1) JPS523051A (fi)
AT (1) AT345979B (fi)
AU (1) AU500027B2 (fi)
CA (1) CA1064906A (fi)
DE (1) DE2628360C2 (fi)
DK (1) DK143905C (fi)
ES (1) ES449257A1 (fi)
FI (1) FI55852C (fi)
FR (1) FR2315296A1 (fi)
GR (1) GR60362B (fi)
IE (1) IE43478B1 (fi)
IT (1) IT1062245B (fi)
LU (1) LU75239A1 (fi)
NL (1) NL7606983A (fi)
NZ (1) NZ181107A (fi)
PT (1) PT65261A (fi)
SE (1) SE7607322L (fi)
SU (1) SU799670A3 (fi)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1581335A (en) * 1976-07-05 1980-12-10 Leo Pharm Prod Ltd 16-s-acyl derivatives of fusidic acid
US4548922A (en) * 1983-06-06 1985-10-22 Beth Israel Hospital Drug administration
US5372996A (en) * 1989-03-10 1994-12-13 Endorecherche, Inc. Method of treatment of androgen-related diseases
CA2062792C (en) * 1989-07-07 2006-03-21 Fernard Labrie Treatment of androgen-related diseases
KR950701527A (ko) * 1992-05-21 1995-04-28 라브리 페르낭 테스토스테론 5α 환원효소 활성 저해제(INHIBITORS OF TESTOSTERONE 5α-REDUCTASE ACTIVITY)

Also Published As

Publication number Publication date
LU75239A1 (fi) 1977-03-16
SE7607322L (sv) 1976-12-26
FI55852C (fi) 1979-10-10
FR2315296B1 (fi) 1980-11-07
IT1062245B (it) 1983-09-20
DK285776A (da) 1976-12-26
JPS6350360B2 (fi) 1988-10-07
ES449257A1 (es) 1977-12-16
IE43478L (en) 1976-12-25
CA1064906A (en) 1979-10-23
JPS523051A (en) 1977-01-11
AU1525076A (en) 1978-01-05
PT65261A (en) 1976-07-01
FI761863A (fi) 1976-12-26
AU500027B2 (en) 1979-05-10
DK143905C (da) 1982-04-19
FI55852B (fi) 1979-06-29
SU799670A3 (ru) 1981-01-23
NZ181107A (en) 1978-11-13
DK143905B (da) 1981-10-26
PT65261B (fi) 1977-12-07
GR60362B (en) 1978-05-19
NL7606983A (nl) 1976-12-28
ATA438776A (de) 1978-02-15
FR2315296A1 (fr) 1977-01-21
IE43478B1 (en) 1981-03-11
DE2628360A1 (de) 1977-01-13
DE2628360C2 (de) 1986-11-06

Similar Documents

Publication Publication Date Title
AT353783B (de) Verfahren zur herstellung von neuen pyrrolidin- -2-on-derivaten
ATA283676A (de) Verfahren zur herstellung von neuen phenylalkancarbonsaure-derivaten
ATA65076A (de) Verfahren zur herstellung von neuen oxadiazolinon-derivaten
AT350197B (de) Verfahren zur herstellung von neuen ebur- nameninderivaten
AT345979B (de) Verfahren zur herstellung von neuen 16-aethern von fusidinsaeurederivaten
AT352298B (de) Verfahren zur herstellung von neuen vincan- derivaten
AT347963B (de) Verfahren zur herstellung von neuen 4- halogenazetidinon-1-essigsaeurederivaten
AT354650B (de) Verfahren zur herstellung von neuen bicyclo- heptenderivaten
AT349656B (de) Verfahren zur herstellung von neuen 1-deoxy- ribofuranuronsaeurederivaten
AT348118B (de) Verfahren zur herstellung von neuen beta- lactamantibiotika
AT353278B (de) Verfahren zur herstellung von neuen azetidin- derivaten
AT353957B (de) Verfahren zur herstellung von neuen cephalos- porinderivaten
AT352714B (de) Verfahren zur herstellung von neuen nitroimi- dazolylvinylthiadiazolen
AT351188B (de) Verfahren zur herstellung von neuen 1,3- benzodioxan-prostansaeurederivaten
AT341541B (de) Verfahren zur herstellung von neuen zinnhaltigen triazino-benzimidazolen
AT349476B (de) Verfahren zur herstellung von neuen phenoxy- alkancarbonsaeurederivaten von 1-cinnamyl-4- diphenylmethylpiperazin
ATA753376A (de) Verfahren zur herstellung von neuen clavulan- saeureaethern
AT346354B (de) Verfahren zur herstellung von neuen 2- morpholinonderivaten
ATA504978A (de) Verfahren zur herstellung von neuen thienothiazinderivaten
ATA252177A (de) Verfahren zur herstellung von neuen 3-amino- crotonsaeureazetidimonderivaten
AT352124B (de) Verfahren zur herstellung von neuen benzo- pyranderivaten
ATA902475A (de) Verfahren zur herstellung von neuen thiadiazolylimidazolinonen
ATA101578A (de) Verfahren zur herstellung von neuen phenyl- alkancarbonsaeurederivaten
AT344145B (de) Verfahren zur herstellung von neuen derivaten der 3-phenyl-2-chlorpropionsaeure
AT348529B (de) Verfahren zur herstellung von neuen naphthyridinderivaten